| Spirig HealthCare AG - Quetiapin XR Spirig HC 300 mg, Retardtabletten |
| 65860 | | 04 | | Quetiapin XR Spirig HC 300 mg | | Retardtabletten | | N05AH04 | | Quetiapine | | 05.07.2016 | | |
|
| Composition |
| quetiapinum 300 mg ut quetiapini fumaras, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, lactosum 85 mg, maltosum monohydricum, talcum, magnesii stearas, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, pro compresso obducto. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Quetiapine | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Quetiapine | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Methacrylici | | Überzug | | Ethylis Acrylatis Polymerisatum | | | | Lactosum | 85 mg | | | Magnesii Stearas | | | | Maltosum Monohydricum | | | | Pro Compresso Obducto | | | | Talcum | | | | Triethylis Citras | | |
| |
|
|
